Talaris Therapeutics, Inc.
NASDAQ:TALS
2.72 (USD) • At close October 19, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -7.015 | -14.738 | -22.497 | -18.528 | -19.011 | -18.096 | -18.259 | -14.241 | -12.941 | -11.352 | -9.299 | -6.779 | -6.417 | -4.663 | -4.848 |
| Depreciation & Amortization
| 0 | 0.261 | 0.639 | 0.553 | 0.57 | 0.551 | 0.488 | 0.188 | 0.167 | 0.133 | 0.135 | 0.125 | 0.129 | 0.101 | 0.092 |
| Deferred Income Tax
| 0 | -15.283 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.109 | 0.193 | 0.226 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 1.174 | 3.659 | 3.072 | 3.041 | 2.846 | 2.197 | 0.994 | 1.053 | 0.896 | 0.835 | 0.593 | 0.186 | 0.12 | 0.123 |
| Change In Working Capital
| 0 | -0.831 | -0.149 | 2.025 | 2.267 | -2.486 | -0.709 | 3.213 | 1.516 | -1.143 | -1.271 | 0.175 | 0.999 | 1.001 | -0.561 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | -0.413 | -0.414 | 1.879 | -0.131 | -0.839 | 0.755 | 1.113 | -0.287 | 0.496 | 0.001 | 0.006 | -0.109 | 0.065 | 0.138 |
| Other Working Capital
| 0 | -0.418 | 0.414 | 0.146 | 2.398 | -1.647 | -1.464 | 2.1 | 1.803 | -1.639 | -1.272 | 0.169 | 1.108 | 0.936 | -0.699 |
| Other Non Cash Items
| 7.015 | 14.738 | 1.446 | -0.992 | -0.294 | -0.095 | 0.003 | 0.016 | 0.076 | 0.484 | 0.553 | 0.236 | 0.277 | -0.052 | -0.049 |
| Operating Cash Flow
| -7.015 | -14.679 | -16.902 | -13.87 | -13.427 | -17.28 | -16.28 | -9.83 | -10.129 | -10.982 | -9.047 | -5.65 | -4.826 | -3.493 | -5.243 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| 0 | -0.221 | -0.32 | -0.269 | -0.341 | -1.092 | -1.341 | -1.189 | -0.726 | -0.335 | -0.187 | -0.249 | -0.342 | -0.346 | -0.349 |
| Acquisitions Net
| 0 | -0.009 | -0.028 | -0.009 | -0.007 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -49.36 | -25.27 | -50.991 | -52.605 | -48.001 | -39.982 | -65.09 | -35.945 | -140.547 | -34.297 | -107.113 | -28.02 | -3.998 | -19.106 |
| Sales Maturities Of Investments
| 0 | 58.5 | 53 | 60.272 | 59.25 | 69.021 | 61.75 | 67 | 38.365 | 40.75 | 35.814 | 3 | 15.314 | 7.91 | 0 |
| Other Investing Activites
| 0 | 0.009 | 0.028 | 0.009 | 0.007 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 8.919 | 27.41 | 9.012 | 6.304 | 19.928 | 20.427 | 0.721 | 1.694 | -100.132 | 1.33 | -104.363 | -13.048 | 3.566 | -19.455 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.137 | 0.046 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0.138 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 0 | 0.137 | 0.046 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0.138 | 0 | -0.524 | 131.623 | 0.024 | 0 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -9.115 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -7.015 | -5.623 | 10.554 | -4.798 | -7.05 | 2.727 | 4.177 | -8.697 | -8.986 | 26.408 | -7.7 | -110.537 | 113.749 | 0.097 | -24.698 |
| Cash At End Of Period
| -7.015 | 18.601 | 24.224 | 13.67 | 18.468 | 25.518 | 22.791 | 18.614 | 27.311 | 36.297 | 9.889 | 17.589 | 128.126 | 14.377 | 14.28 |